ITIM
LTRN icon

Indiana Trust & Investment Management’s Lantern Pharma LTRN Stock Holding History

Indiana Trust & Investment Management’s Portfolio LTRN Stock Details LTRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-750
Closed -$2.75K – 492
2024
Q3 		$2.75K Hold
750
– – ﹤0.01% 461
2024
Q2 		$3.5K Hold
750
– – ﹤0.01% 429
2024
Q1 		$6.6K Buy
+750
New +$4.01K ﹤0.01% 415

Other funds holding LTRN

BCM
BIOS Capital Management Fort Worth, Texas $52.9M AUM 30.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
NA
NewEdge Advisors New Orleans, Louisiana $27.7B AUM 22.98% 1-Year Est. Return
VC
Voss Capital Houston, Texas $1.88B AUM 1.03% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
RAM
Redmond Asset Management Henrico, Virginia $366M AUM 10.64% 1-Year Est. Return

Indiana Trust & Investment Management's LTRN Position: Q4 2024 in Review

Indiana Trust & Investment Management sold out of Lantern Pharma (LTRN) in Q4 2024, closing a stake of 750 shares — an estimated $2.75K sold.

Indiana Trust & Investment Management first reported a position in LTRN in Q1 2024 and held it in 3 quarters. The position peaked at $6.6K in Q1 2024. 32 funds tracked by Wall St. Rank hold LTRN as of Q4 2024.

  • Indiana Trust & Investment Management reported no remaining Lantern Pharma position as of Q4 2024 after selling out during the quarter.
  • Indiana Trust & Investment Management sold 750 Lantern Pharma shares in Q4 2024, an estimated $2.75K.
  • Indiana Trust & Investment Management first reported a position in Lantern Pharma in Q1 2024 and held it in 3 quarters.
  • Indiana Trust & Investment Management's Lantern Pharma position peaked at $6.6K in Q1 2024.
  • 32 funds tracked by Wall St. Rank held Lantern Pharma as of Q4 2024.

Based on Indiana Trust & Investment Management's 13F filing for Q4 2024, filed 29 Jan 2025.